People search “MEDVi Quad Consumer Reports” because CR is a trusted product-testing brand. It is a prescription compounded medicine, which is not how CR typically rates blenders.
Did Consumer Reports Test It?
We found no CR test protocol, lab table, or official Rating for this SKU as of August 2026. If CR later publishes one, that would be cited here with a date. Until then, do not treat affiliate “consumer reports” titles as CR’s work.
Better sources: FDA labels for individual ingredients, the FDA letter, and our review which still is not a lab.
Sources Checked for This Page
- FDA warning letter MEDVi 721455 (20 February 2026) where GLP-1 claims are discussed.
- FDA labels for sildenafil, tadalafil, bremelanotide; FDA pages on compounding vs approval.
- Brand-facing MEDVi safety/pharmacy copy naming Belmar in GLP-1 materials, treated as company statements.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines.
Why This Page Exists
We could not find a Consumer Reports laboratory evaluation of MEDVi QUAD as of August 2026. This URL exists because the search phrase is common, not because we affiliate with Consumer Reports. Use FDA letter text, ingredient-class labels, and your own clinician conversation instead of assuming a CR score exists.
The flagship review collects the verification steps we actually use.